Protara Therapeutics Inc (TARA) Insider Trading
- $6,774,196.11
- $1,580,348.14
- Sept. 11, 2024
- Opaleye Management Inc.
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 11, 2024 | Major Shareholder | 32,600 | $1.71 | Sell | $55,746.00 | |
Sept. 9, 2024 | Major Shareholder | 36,492 | $1.89 | Sell | $68,969.88 | |
July 16, 2024 | Major Shareholder | 11,396 | $2.44 | Sell | $27,806.24 | |
July 11, 2024 | Major Shareholder | 47,993 | $2.40 | Sell | $115,183.20 | |
July 9, 2024 | Major Shareholder | 8,497 | $2.21 | Sell | $18,778.37 | |
July 1, 2024 | Major Shareholder | 8,288 | $2.12 | Sell | $17,570.56 | |
June 27, 2024 | Major Shareholder | 46,574 | $2.26 | Sell | $105,257.24 | |
June 25, 2024 | Major Shareholder | 12,725 | $2.26 | Sell | $28,758.50 | |
May 30, 2024 | Major Shareholder | 9,230 | $2.94 | Sell | $27,136.20 | |
May 21, 2024 | Major Shareholder | 33,000 | $3.06 | Sell | $100,980.00 | |
May 17, 2024 | Major Shareholder | 70,885 | $3.25 | Sell | $230,376.25 | |
May 9, 2024 | Major Shareholder | 30,600 | $3.09 | Sell | $94,554.00 | |
Sept. 14, 2022 | Major Shareholder | 16,600 | $3.98 | Buy | $66,068.00 | |
Aug. 11, 2022 | CEO | 9,065 | $3.84 | Buy | $34,809.60 | |
June 30, 2022 | Director | 10,000 | $3.10 | Buy | $31,000.00 | |
April 7, 2022 | Major Shareholder | 2,345 | $4.74 | Buy | $11,115.30 | |
March 14, 2022 | Director | 10,000 | $4.25 | Buy | $42,500.00 | |
March 10, 2022 | Director | 10,000 | $4.46 | Buy | $44,600.00 | |
Jan. 28, 2022 | Major Shareholder | 24,031 | $4.96 | Buy | $119,193.76 | |
Dec. 29, 2021 | Major Shareholder | 4,500 | $6.98 | Buy | $31,410.00 | |
Dec. 27, 2021 | Major Shareholder | 36,700 | $6.53 | Buy | $239,651.00 | |
Dec. 23, 2021 | Major Shareholder | 1,300 | $6.60 | Buy | $8,580.00 | |
Dec. 20, 2021 | Major Shareholder | 703 | $6.49 | Buy | $4,562.47 | |
Dec. 16, 2021 | Major Shareholder | 7,563 | $6.41 | Buy | $48,478.83 | |
Nov. 17, 2021 | Major Shareholder | 9,118 | $6.98 | Buy | $63,643.64 | |
Nov. 4, 2021 | Major Shareholder | 6,557 | $6.50 | Buy | $42,620.50 | |
June 10, 2021 | Insider | 9,893 | $10.10 | Buy | $99,919.30 | |
Sept. 30, 2020 | Major Shareholder | 50,000 | $16.00 | Buy | $800,000.00 | |
Sept. 24, 2020 | Major Shareholder | 300,000 | $16.87 | Buy | $5,061,000.00 | |
Sept. 22, 2020 | CFO | 1,481 | $16.91 | Buy | $25,043.71 | |
Sept. 14, 2020 | Major Shareholder | 2,554 | $19.40 | Sell | $49,547.60 | |
Sept. 10, 2020 | Major Shareholder | 239 | $18.00 | Sell | $4,302.00 | |
Sept. 8, 2020 | Major Shareholder | 3,108 | $18.94 | Sell | $58,865.52 | |
Sept. 2, 2020 | Major Shareholder | 207 | $20.68 | Sell | $4,280.76 | |
Aug. 28, 2020 | Major Shareholder | 771 | $22.09 | Sell | $17,031.39 | |
Aug. 24, 2020 | Major Shareholder | 974 | $23.16 | Sell | $22,557.84 | |
Aug. 20, 2020 | Major Shareholder | 510 | $24.18 | Sell | $12,331.80 | |
Aug. 17, 2020 | Major Shareholder | 1,548 | $25.11 | Sell | $38,870.28 | |
Aug. 14, 2020 | Major Shareholder | 700 | $25.09 | Sell | $17,563.00 | |
July 29, 2020 | Major Shareholder | 2,516 | $26.42 | Sell | $66,472.72 | |
July 27, 2020 | Major Shareholder | 338 | $26.08 | Sell | $8,815.04 | |
July 24, 2020 | Major Shareholder | 2,343 | $26.53 | Sell | $62,159.79 | |
July 22, 2020 | Major Shareholder | 1,372 | $26.73 | Sell | $36,673.56 | |
July 20, 2020 | Major Shareholder | 4,330 | $26.79 | Sell | $116,000.70 | |
July 17, 2020 | Major Shareholder | 1,601 | $26.66 | Sell | $42,682.66 | |
July 13, 2020 | Major Shareholder | 2,145 | $27.13 | Sell | $58,193.85 | |
July 10, 2020 | Major Shareholder | 2,659 | $27.41 | Sell | $72,883.19 |
Insiders are both buying and selling Protara Therapeutics Inc stock.
The insider traders at Protara Therapeutics Inc are: Opaleye Management Inc., Randall Marshall, Luke M Beshar, Blaine Davis, Jesse Shefferman, and Martin Sebastian Olivo
The most active insider trader at Protara Therapeutics Inc is Opaleye Management Inc. with 24 trades.
Opaleye Management Inc. has sold the most Protara Therapeutics Inc stock with a total value of $946,862.44.
Opaleye Management Inc. has bought the most Protara Therapeutics Inc stock with a total value of $6,562,391.50.
The most recent insider trade for Protara Therapeutics Inc was on Sept. 11, 2024.
The single biggest insider buy for Protara Therapeutics Inc was from Opaleye Management Inc. with a total value of $5,061,000.00 on Sept. 24, 2020.
The single biggest insider sell for Protara Therapeutics Inc was from Opaleye Management Inc. with a total value of $230,376.25 on May 17, 2024.